Mar 6, 2026 06:50AM
Feb 18, 2026 09:17AM
Feb 17, 2026 07:33AM
Feb 6, 2026 04:45AM
Jan 7, 2026 12:42AM
Jan 6, 2026 09:41AM
Dec 12, 2025 09:16AM Citi Opens 90-Day Upside Catalyst Watch on Ideaya Biosciences (IDYA)
Dec 10, 2025 06:01AM
Dec 5, 2025 04:26PM
Dec 1, 2025 06:00AM
Nov 24, 2025 07:34AM
Nov 4, 2025 06:26AM
Oct 21, 2025 04:16AM
Oct 13, 2025 04:34AM Citizens Reiterates Market Outperform on Ideaya Biosciences (IDYA); Bullish on Darovasertib
Oct 7, 2025 07:53AM
Oct 4, 2025 04:00PM
Sep 23, 2025 08:53AM
Sep 12, 2025 05:40AM
Sep 11, 2025 08:18AM
Sep 9, 2025 09:19AM
Sep 9, 2025 08:53AM Cantor Fitzgerald Reiterates Overweight Rating on Ideaya Biosciences (IDYA)
Sep 9, 2025 07:00AM
Sep 9, 2025 04:04AM
Sep 8, 2025 04:14AM
Sep 4, 2025 03:54AM
Sep 4, 2025 03:33AM
Sep 3, 2025 06:57AM
Sep 3, 2025 06:00AM IDEAYA Biosciences submits IND for PRMT5 inhibitor IDE892
Sep 2, 2025 06:01AM
Aug 18, 2025 06:01AM
Aug 5, 2025 06:23AM
Aug 5, 2025 06:21AM
Jul 30, 2025 06:40AM
Jul 22, 2025 01:01PM
Jul 22, 2025 05:43AM TD Cowen Starts Ideaya Biosciences (IDYA) at Buy
Jul 10, 2025 06:29AM
Jul 9, 2025 10:35AM
Jun 26, 2025 06:23AM
May 6, 2025 06:33AM
May 6, 2025 06:01AM
Apr 14, 2025 06:00AM
Mar 31, 2025 06:29AM IDEAYA Biosciences (IDYA) Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma
Feb 13, 2025 06:27AM
Feb 13, 2025 06:04AM
Feb 10, 2025 06:02AM
Jan 21, 2025 06:24AM
Jan 2, 2025 04:00PM
Dec 30, 2024 04:19AM
Dec 21, 2024 10:00AM RBC report: Biotech faces both uncertainty and growth opportunities in 2025
Dec 17, 2024 08:17AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All